In a blaze of hope, the first drug to be believed to prolong the lives of those with HIV infections is hailed as a potential ‘miracle cure'. Trials are underway and hopes are high. But soon, severe and debilitating side effects begin to show themselves, and many of those participating in the trials become desperately sick. The results of the failed AZT trials are released in 1993 and provoke backlash against drug companies and sometimes the doctors and nurses caring for Aids patients.
